Evidence map›Paper›PMID 32458199›Full record

ArticleJournal of neurology2020

A parsimonious score with a free web tool for predicting disability after an ischemic stroke: the Parsifal Score.

E Muiño, A Bustamante, A Rodriguez-Campello, C Gallego-Fabrega, A Ois, C Carrera, N Cullell, N Torres-Aguila, J Cárcel-Márquez, M Rubiera and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

E MuiñoStroke Pharmacogenomics and Genetics, Fundació Mutua Terrassa per la Docència i la Recerca Biomèdica i Social FPC, Barcelona, Spain.
A BustamanteNeurovascular Research Laboratory, Vall d'Hebron Institute of Research, Hospital Vall d'Hebron-UAB, Barcelona, Spain.
A Rodriguez-CampelloNeurology Service, IMIM-Hospital del Mar, Barcelona, Spain.
C Gallego-FabregaStroke Pharmacogenomics and Genetics, Fundació Mutua Terrassa per la Docència i la Recerca Biomèdica i Social FPC, Barcelona, Spain.
A OisNeurology Service, IMIM-Hospital del Mar, Barcelona, Spain.
C CarreraFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
N CullellStroke Pharmacogenomics and Genetics, Fundació Mutua Terrassa per la Docència i la Recerca Biomèdica i Social FPC, Barcelona, Spain.
N Torres-AguilaStroke Pharmacogenomics and Genetics, Fundació Mutua Terrassa per la Docència i la Recerca Biomèdica i Social FPC, Barcelona, Spain.
J Cárcel-MárquezStroke Pharmacogenomics and Genetics, Fundació Mutua Terrassa per la Docència i la Recerca Biomèdica i Social FPC, Barcelona, Spain.
M RubieraNeurology Service, Hospital Vall D'Hebron, Barcelona, Spain.
C A MolinaNeurology Service, Hospital Vall D'Hebron, Barcelona, Spain.
E Cuadrado-GodiaNeurology Service, IMIM-Hospital del Mar, Barcelona, Spain.
E Giralt-SteinhauerNeurology Service, IMIM-Hospital del Mar, Barcelona, Spain.
J Jiménez-CondeNeurology Service, IMIM-Hospital del Mar, Barcelona, Spain.
J MontanerNeurovascular Research Laboratory, Vall d'Hebron Institute of Research, Hospital Vall d'Hebron-UAB, Barcelona, Spain.
I Fernández-CadenasFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. israelcadenas@yahoo.es.ORCID http://orcid.org/0000-0003-4821-2363
J RoquerNeurology Service, IMIM-Hospital del Mar, Barcelona, Spain.

Funding

Instituto de Salud Carlos III 2019_FI_B 00853Instituto de Salud Carlos III CM18/00198Instituto de Salud Carlos III JR16/00008
6 · The paper itself

Abstract

backgroundMost of the models to predict prognosis after an ischemic stroke include complex mathematical equations or too many variables, making them difficult to use in the daily clinic. We want to predict disability 3 months after an ischemic stroke in an independent patient not receiving recanalization treatment within the first 24 h, using a minimum set of variables and an easy tool to facilitate its implementation. As a secondary aim, we calculated the capacity of the score to predict an excellent/devastating outcome and mortality.

methodsEight hundred and forty-four patients were evaluated. A multivariable ordinal logistic regression was used to obtain the score. The Modified Rankin Scale (mRS) was used to estimate disability at the third month. The results were replicated in another independent cohort (378 patients). The "polr" function of R was used to perform the regression, stratifying the sample into seven groups with different cutoffs (from mRS 0 to 6).

resultsThe Parsifal score was generated with: age, previous mRS, initial NIHSS, glycemia on admission, and dyslipidemia. This score predicts disability with an accuracy of 80-76% (discovery-replication cohorts). It has an AUC of 0.86 in the discovery and replication cohort. The specificity was 90-80% (discovery-replication cohorts); while, the sensitivity was 64-74% (discovery-replication cohorts). The prediction of an excellent or devastating outcome, as well as mortality, obtained good discrimination with AUC > 0.80.

conclusionsThe Parsifal Score is a model that predicts disability at the third month, with only five variables, with good discrimination and calibration, and being replicated in an independent cohort.

Indexed as

Brain IschemiaIschemic StrokePersons with DisabilitiesDisability EvaluationHumansPrognosisTreatment OutcomeDisabilityModified Rankin ScaleStrokeWeb tool

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.